Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Posted
iFresh Inc is a grocery stores business based in the US. iFresh shares (IFMK) are listed on the NASDAQ and all prices are listed in US Dollars. iFresh employs 276 staff and has a trailing 12-month revenue of around USD$94.3 million.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
52-week range | USD$0.345 - USD$2.83 |
---|---|
50-day moving average | USD$1.3157 |
200-day moving average | USD$0.9481 |
Wall St. target price | N/A |
PE ratio | 72.4 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$0.025 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing iFresh stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of iFresh's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
iFresh's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, iFresh shares trade at around 72x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
iFresh's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$433,894.
The EBITDA is a measure of a iFresh's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$94.3 million |
---|---|
Gross profit TTM | USD$16.8 million |
Return on assets TTM | -1.49% |
Return on equity TTM | 7.29% |
Profit margin | 0.79% |
Book value | $0.348 |
Market capitalisation | USD$65.7 million |
TTM: trailing 12 months
There are currently 512,569 iFresh shares held short by investors – that's known as iFresh's "short interest". This figure is 1.2% up from 506,373 last month.
There are a few different ways that this level of interest in shorting iFresh shares can be evaluated.
iFresh's "short interest ratio" (SIR) is the quantity of iFresh shares currently shorted divided by the average quantity of iFresh shares traded daily (recently around 1.3 million). iFresh's SIR currently stands at 0.41. In other words for every 100,000 iFresh shares traded daily on the market, roughly 410 shares are currently held short.
However iFresh's short interest can also be evaluated against the total number of iFresh shares, or, against the total number of tradable iFresh shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case iFresh's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 iFresh shares in existence, roughly 10 shares are currently held short) or 0.0193% of the tradable shares (for every 100,000 tradable iFresh shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against iFresh.
Find out more about how you can short iFresh stock.
We're not expecting iFresh to pay a dividend over the next 12 months.
Over the last 12 months, iFresh's shares have ranged in value from as little as $0.345 up to $2.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while iFresh's is -3.1888. This would suggest that iFresh's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, iFresh has bucked the trend.
iFresh Inc., through its subsidiaries, operates a network of grocery supermarket chains in the north-eastern United States. It operates through Wholesale and Retail segments. The company provides vegetables, seafood, meat, fruits, snacks, seasonings, and spices, such as peanut oil, cooking wine, vinegar, dark soy sauce, black bean sauce, pepper oil, and chilly oil; tea, condiments, canned goods, flour products, marine food products, candies groceries, traditional Chinese medicine, health products, and dried food; rice and rice products; assortment of noodles, frozen vegetables, frozen dumplings, frozen seafood products, and aquatic products; and cooking utensils. Its brand portfolio includes Family Elephant, Feiyan, Green Acre, Golden Smell, Redolent, and I FRESH. The company also distributes its products to wholesale stores, retail supermarkets, and restaurants. As of August 10, 2020, it operated nine retail supermarkets and two in-house wholesale businesses. The company offers its products through online sales channels and delivery network in suburban areas. iFresh Inc. was founded in 1995 and is headquartered in Long Island City, New York.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.